Target intelligence / Profile preview

Misfolded client proteins

Molecular classification
Other
01

Overview

Misfolded client proteins refer to a broad class of proteins that require the assistance of molecular chaperones, most notably Heat Shock Protein 90 (Hsp90) and Hsp70, to maintain their functional three-dimensional conformation. These clients include a wide array of signaling kinases, steroid receptors, and transcription factors that are essential for cellular growth and survival. In the context of disease, particularly oncology, many client proteins are mutated or overexpressed (e.g., HER2, BRAF, BCR-ABL), making the cell hypersensitive to chaperone inhibition. When the chaperone-client interaction is disrupted by drugs, these proteins fail to fold correctly, become unstable, and are subsequently targeted for degradation via the ubiquitin-proteasome pathway. This mechanism allows for the simultaneous depletion of multiple oncogenic drivers, though it also presents challenges regarding systemic toxicity due to the essential nature of many client proteins in normal physiology.

Other names
Hsp90 client proteinsChaperone clientsUnfolded proteinsProteotoxic substrates
02

Mechanism of action

Inhibition of molecular chaperones (e.g., Hsp90) leads to the destabilization, misfolding, and proteasomal degradation of client proteins; Proteasome inhibition leads to the toxic accumulation of misfolded proteins inducing apoptosis.

03

Biological functions

Protein foldingProteostasisSignal transductionCell cycle regulationApoptosis
04

Disease associations

CancerNeurodegenerative diseaseCystic fibrosisAmyloidosis
05

Safety considerations

HepatotoxicityOcular toxicity (visual disturbances)Gastrointestinal distressFatigueOff-target effects on essential cellular signaling
06

Interacting drugs

Tanespimycin (17-AAG)

5 more in the full profile.

07

Biomarkers

Hsp70 inductionHER2 degradationBCR-ABL levelsUbiquitinated protein accumulation

Beyond the preview

Go deeper on Misfolded client proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Misfolded client proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call